author-photo

F.E. de Jongh

Erasmus University Medical Center

18

Papers

544

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P1-02-02: ESR1 mutations in circulating tumor cell versus circulating cell-free DNA of metastatic breast cancer patients before first-line endocrine therapy and at progression

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

2017 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (26)
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (37)
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

2014 The Breast
Show All
- Source
- Cite
- Save
Citations (88)
249 Feasibility and Toxicities Associated with PEG Doxo Versus Capecitabine as First-line Chemotherapy in Elderly Metastatic Breast Cancer (MBC) Patients; Results From the Randomized OMEGA Study of the Dutch Breast Cancer Trialists’ Group (BOOG)

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P1-12-05: First-line chemotherapy with pegylated liposomal doxorubicin versus capecitabine in elderly patients with metastatic breast cancer: results of the phase III OMEGA study of the Dutch Breast Cancer Trialists' Group (BOOG)

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Cisplatin-induced encephalopathy and seizures

2003 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (57)
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

2003 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (183)